» Articles » PMID: 36202956

Anti-hyperalgesic Effects of Photobiomodulation Therapy (904 nm) on Streptozotocin-induced Diabetic Neuropathy Imply MAPK Pathway and Calcium Dynamics Modulation

Abstract

Several recent studies have established the efficacy of photobiomodulation therapy (PBMT) in painful clinical conditions. Diabetic neuropathy (DN) can be related to activating mitogen-activated protein kinases (MAPK), such as p38, in the peripheral nerve. MAPK pathway is activated in response to extracellular stimuli, including interleukins TNF-α and IL-1β. We verified the pain relief potential of PBMT in streptozotocin (STZ)-induced diabetic neuropathic rats and its influence on the MAPK pathway regulation and calcium (Ca) dynamics. We then observed that PBMT applied to the L4-L5 dorsal root ganglion (DRG) region reduced the intensity of hyperalgesia, decreased TNF-α and IL-1β levels, and p38-MAPK mRNA expression in DRG of diabetic neuropathic rats. DN induced the activation of phosphorylated p38 (p-38) MAPK co-localized with TRPV1 neurons; PBMT partially prevented p-38 activation. DN was related to an increase of p38-MAPK expression due to proinflammatory interleukins, and the PBMT (904 nm) treatment counteracted this condition. Also, the sensitization of DRG neurons by the hyperglycemic condition demonstrated during the Ca dynamics was reduced by PBMT, contributing to its anti-hyperalgesic effects.

Citing Articles

Effect of photobiomodulation as preventive treatment of diabetic foot ulcer: randomised, controlled, double-blind, clinical trial protocol.

Lourenco R, Perez S, Motta L, Gutierrez Duran C, Padilha A, Bussadori S BMJ Open. 2025; 15(1):e094594.

PMID: 39843368 PMC: 11784213. DOI: 10.1136/bmjopen-2024-094594.


Keratinocyte-derived extracellular vesicles in painful diabetic neuropathy.

Coy-Dibley J, Jayaraj N, Ren D, Pacifico P, Belmadani A, Wang Y Neurobiol Pain. 2025; 17:100176.

PMID: 39811188 PMC: 11731614. DOI: 10.1016/j.ynpai.2024.100176.


Photobiomodulation for diabetes and its complications: a review of general presentation, mechanisms and efficacy.

Wang K, Zhao H, Zhao X, Zhang X, Zhang W, Cheng Y Ann Med. 2024; 56(1):2433684.

PMID: 39607829 PMC: 11610354. DOI: 10.1080/07853890.2024.2433684.


Keratinocyte-Derived Exosomes in Painful Diabetic Neuropathy.

Coy-Dibley J, Jayaraj N, Ren D, Pacifico P, Belmadani A, Wang Y bioRxiv. 2024; .

PMID: 39229068 PMC: 11370388. DOI: 10.1101/2024.08.21.608803.


Role of microglia in diabetic neuropathic pain.

Wang Q, Xie Y, Ma S, Luo H, Qiu Y Front Cell Dev Biol. 2024; 12:1421191.

PMID: 39135776 PMC: 11317412. DOI: 10.3389/fcell.2024.1421191.


References
1.
Aleksic V, Aoki A, Iwasaki K, Takasaki A, Wang C, Abiko Y . Low-level Er:YAG laser irradiation enhances osteoblast proliferation through activation of MAPK/ERK. Lasers Med Sci. 2010; 25(4):559-69. DOI: 10.1007/s10103-010-0761-5. View

2.
Thornalley P . Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol. 2002; 50:37-57. DOI: 10.1016/s0074-7742(02)50072-6. View

3.
Chung H, Dai T, Sharma S, Huang Y, Carroll J, Hamblin M . The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2011; 40(2):516-33. PMC: 3288797. DOI: 10.1007/s10439-011-0454-7. View

4.
Chow R, Johnson M, Lopes-Martins R, Bjordal J . Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet. 2009; 374(9705):1897-908. DOI: 10.1016/S0140-6736(09)61522-1. View

5.
Hamblin M . Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol. 2017; 94(2):199-212. PMC: 5844808. DOI: 10.1111/php.12864. View